Review on Liver Steatosis and its Impact on Liver Transplantation

Submit Manuscript | http://medcraveonline.com Abbreviations: ALT: Alanine Amino Transferases; AST: Aspartate Amino Transferases; AUROC: Area Under the Receiver Operating Characteristic Curve; BMI: Body Mass Index; CIT: Cold Ischemia Time; CT: Computed Tomography; D-MELD: Donor Age Multiplied with the Recipient Model for End-Stage Liver Disease; ECD: Extended Criteria Donor; EGD: Early Graft Dysfunction; ELF: Enhanced Liver Fibrosis; ESLD: End-Stage Liver Disease; FA: Fatty Acids; FIB-4: Fibrosis-4; FLI: Fatty Liver Index; FLIP: Fatty Liver Inhibition of Progression; GGT: Gamma-Glutamyl Transpeptidase; HCC: Hepatocellular Carcinoma; HCV: Hepatitis C Virus; IP: Ischemic Preconditioning; IR: Insulin Resistance; I/R: Ischemia Reperfusion; LDLT: Living Donor Liver Transplantation; LSM: Liver Stiffness Measurement; LT: Liver Transplantation; MaS: Macrosteatosis; MetS: Metabolic Syndrome; MiS: Microsteatosis; MELD: Model For End-Stage Liver Disease; MR: Magnetic Resonance; NAFL: Non-Alcoholic Fatty Liver; NAFLD: NonAlcoholic Fatty Liver Disease; NAS: NAFLD Activity Score; NASH: Non-Alcoholic Steatohepatitis; NFS: NAFLD Fibrosis Score; NPV: Negative Predictive Value; PNF: Primary Non-Function; PPV: Positive Predictive Value; ROS: Reactive Oxygen Species; T2DM: Type 2 Diabetes Mellitus; Tnf-α: Tumor Necrosing Factor Α; UNOS: United Network of Organ Sharing; WIT: Warm Ischemia Time